Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya

by Doreen Lugano, Bernadette Kutima, Makobu Kimani, Antipa Sigilai, John Gitonga, Angela Karani,, Donald Akech, Boniface Karia, Abdhalah K. Ziraba, Angela Maina, Arnold Lambisia, Donwilliams Omuoyo, Daisy Mugo, Ruth Lucinde, Sharon Owuor, Gloria Konyino, Joseph Newman, Dalan Bailey,, Eunice Nduati, George Githinji, Charles N. Agoti, Philip Bejon, J. Anthony G. Scott,, Ambrose Agweyu, Wangeci Kagucia, George M. Warimwe, Charles Sande, Lynette I. Ochola-Oyier, James Nyagwange
10th January 2025 • comment

Open Letter: Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium

by Le Nguyen Truc Nhu et al.
14th August 2024 • comment

Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2

by Mariana O Diniz et al
21st May 2024 • comment

High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia

by Sheikh Jarju et al.
21st May 2024 • comment

Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation

by Alex Sigal et al
22nd April 2024 • comment

Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant

by Alex Sigal et al
22nd April 2024 • comment